Capricorn Pharma is a specialty state-of-the-art pharmaceutical, technology driven company, engaged in innovation, development, commercialization and manufacturing of pharmaceutical products - Orally Disintegrating Dosage (O.D.D) forms, KORTABS - modified release dosage forms, and Micro-encapsulations with multiple processes.

CPI mission and strategy:

• Increase Shareholders value - solid revenue base from development and manufacturing with good profit margins and sustainable growth

• Develop  Human Capital leading to continuous innovation

• Portfolio of value added Oral Drug Delivery systems- innovative multiple advanced technologies with broad applications across range of products in different therapeutic categories

• Targeted products profile include improved compliance and easy administration, control of blood level of drugs, improve efficacy, reduce side effects and expand indications

• Manufacture quality products that meet US FDA cGMP and other US and International regulatory requirements

• Develop global business relationships and alliances for product development, licensing and product sale.